VOV. D. Oleynikova

V. D. Oleynikova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


V. D. Oleynikova has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Sentinel lymph node biopsy in breast carcinoma in situ

    by I.M. Onofriychuk, A.D. Zikiryahodzhaev, E.K. Saribekyan, S.I. Mikhailov, V.S. Surkova, N.N. Volchenko, V.D. Oleynikova

    Due to the rapid development of breast cancer screening and its detection more often in earlier stages, preinvasive forms of breast cancer account for up to 20% of all forms of malignant neoplasms of the breast. Therefore, today in the treatment of breast cancer with ductal carcinoma in situ (DCIS) there is a tendency to de-escalate surgical intervention. This article reviews the literature, as well as current domestic and international clinical guidelines for the treatment of DCIS in order to study the frequency of detection of metastatic lesions during sentinel lymph node examination (SLNB), and assesses the feasibility and indications for SLNB. The findings of the current review article can supplement the existing data on the indications for SLNB in patients with DCIS and help clarify the recommendations for the treatment of ductal carcinoma in situ (DCIS).


  • Open Access

    Rare Disease: Breast Desmoid-Type Fibromatosis.

    by I. M. Onofriychuk, A. D. Zikiryahodzhaev, S. I. Mikhailov, V. D. Oleynikova, G. M. Zapirov, S. B. Zapirova, A. M. Lavrova, N. N. Volchenko, E. K. Saribekyan

    The article presents a rare form of pathological neoplasms — breast desmoid type fibromatosis. There are etiology and pathogenesis of the disease, clinical and morphological features, diagnostics and tactics of treatment of the disease. Widely covered clinical examples from the practice of a surgeon-oncologist. Desmoid fibromatosis (DF) is an aggressive non-metastatic mesenchymal formation that arises from musculoponeurotic structures. DF accounts for 0.03 % to 0.1 % of solid tumors and 3 % of mesenchymal tumors. Among breast pathology, this neoplasm is even rarer (0.2 %). Due to the rarity of such pathology, clinicians are not always able to correctly interpret the diagnostic picture and recognize the disease. The etiology and pathogenesis of the disease are also not fully understood, and therefore there are no standards for the treatment of desmoid fibromatosis. Surgical treatment remains the main one. To reduce the frequency of recurrence of the disease, the surgeon needs to achieve clean edges of the resection. Radiation therapy, hormone therapy, targeted therapy, and chemotherapy may additionally be considered as an alternative type of treatment. When the clean edges of the resection are reached, strict dynamic monitoring of pa is considered as further treatment.

  • Open Access

    Prediction of vascular events in individuals with atherosclerotic lesions of various vascular basins: results of a 3-year prospective follow-up

    by N. D. Kobzeva, В. П. Терентьев, V. D. Oleynikova

    Introduction. Today, cardiovascular diseases occupy a leading position in the structure of mortality, both in Russia and throughout the world. Every year more than 17 million people die from cardiac pathology, according to the World Health Organization, an increase in morbidity and mortality is expected in the future, which is explained, first of all, by an increase in the number of patients with diabetes and obesity.Aim. Development of optimal approaches to predicting cardiovascular events and unfavorable outcomes in patients with peripheral atherosclerosis during a 3-year prospective follow-up.Materials and methods. The study included 519 patients with atherosclerotic lesions of various vascular regions, of which 360 (69.4%) were men, 159 (30.6%) were women. The average age of the examined patients was 60.0 ± 8.7 years.Results. In the course of the analysis, it was noted that a factor such as the percentage of table stenosis of the left coronary artery (p = 0.013) influenced the risk of developing non-fatal cases of heart failure in patients with peripheral atherosclerosis. With regard to the end point – fatal cases of heart failure, the following factors demonstrated their statistical significance: age of onset of arterial hypertension, years (p = 0.020); history of chronic heart failure (p = 0.020); left atrial size, mm (p = 0.025); degree of stenosis of the posterior lateral branch, % (p = 0.038); presence of atherosclerotic lesions in the region of the posterior interventricular branch (p = 0.002); number of affected vascular beds (p = 0.044).Conclusions. Using logistic regression equations, original mathematical tools have been developed to assess the risk of developing both fatal and non-fatal heart failure in patients with peripheral atherosclerosis.

  • Open Access

    Features of Prediction of Heart Failure in Patients with Peripheral Atherosclerosis During a Three-Year Prospective Follow-Up

    by N. D. Kobzeva, В. П. Терентьев, V. D. Oleinikova

    ОСОБЕННОСТИ ПРОГНОЗИРОВАНИЯ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ У ПАЦИЕНТОВ С ПЕРИФЕРИЧЕСКИМ АТЕРОСКЛЕРОЗОМ В ТЕЧЕНИЕ ТРЕХЛЕТНЕГО ПРОСПЕКТИВНОГО НАБЛЮДЕНИЯ